Elevated cardiac risk in patients with major depressive disorder

American Journal of Psychiatry

Volumn 165, Issue 1, 2008, Pages 137-

  Bayles, Richard G ^a   Dawood, Tye ^a   Lambert, Elisabeth A ^a   Schlaich, Markus P ^a   Lambert, Gavin W ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

SEROTONIN TRANSPORTER; SEROTONIN UPTAKE INHIBITOR; SLC6A4 PROTEIN, HUMAN; UNCLASSIFIED DRUG;

ALLELE; CARDIOVASCULAR RISK; DNA POLYMORPHISM; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; LETTER; MAJOR DEPRESSION; MORBIDITY; MORTALITY; PRIORITY JOURNAL; ADRENERGIC SYSTEM; AUTONOMIC NEUROPATHY; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; HEART; HEART LEFT VENTRICLE HYPERTROPHY; INNERVATION; NOTE; PATHOPHYSIOLOGY; PHYSIOLOGY; RISK FACTOR;

AUTONOMIC NERVOUS SYSTEM DISEASES; CARDIOVASCULAR DISEASES; COHORT STUDIES; DEPRESSIVE DISORDER, MAJOR; GENETIC PREDISPOSITION TO DISEASE; HEART; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; POLYMORPHISM, GENETIC; RISK FACTORS; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SYMPATHETIC NERVOUS SYSTEM;

EID: 39049130680     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.2007.07091377     Document Type: Letter

References (6)

1. Otte C, McCaffrey J, Ali S, Whooley MA: Association of serotonin transporter polymorphism (5-HTTLPR) with depression, perceived stress, and norepinephrine in patients with coronary disease: the Heart and Soul Study. Am J Psych 2007; 164:1379-1384
2. Meredith IT, Broughton A, Jennings GL, Esler MD: Evidence of a selective increase in cardiac sympathetic activity in patients with sustained ventricular arrhythmias. N Engl J Med 1991; 325:618-624
3. Schlaich MP, Kaye DM, Lambert E, Sommerville M, Socratous F, Esler MD: Relation between cardiac sympathetic activity and hypertensive left ventricular hypertrophy. Circulation 2003; 108:560-565
4. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP: Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990; 322:1561-1566
5. Esler M, Jennings G, Lambert G: Measurement of overall and cardiac norepinephrine release into plasma during cognitive challenge. Psychoneuroendocrinology 1989; 14:477-481
6. Barton DA, Dawood T, Lambert EA, Esler MD, Haikerwal D, Brenchley C, Socratous F, Kaye DM, Schlaich MP, Hickie I, Lambert GW: Sympathetic activity in major depressive disorder: identifying those at increased cardiac risk? J Hypertens 2007; 25:2117-2124